CHILDREN WITH AUTISM
SPECTRUM DISORDERS (ASD)

Pilot Study

shutterstock_1463202677 1 (1).png
shutterstock_1221615613 [Converted]-01 (

METHODOLOGY

shutterstock_429937732 [Converted]-02.pn

1

PARTICIPANTS
  • Children diagnosed with ASD.

  • Currently using medical cannabis under HCP supervision.

  • Living in California (Los Angeles and San Francisco Bay Area).

PRIVACY
  • Children’s data privacy is protected by HIPAA-compliant protocols.

shutterstock_429937732 [Converted]-03.pn

2

Cannformatics-HeroBanner-04.png

3

SAMPLES
  • ASD: Saliva collected from children pre- and post-consumption of regularly prescribed medical cannabis dosage. 

  • Control: Saliva collected from age-matched neurotypical children.

ANALYSIS
  • Cannformatics’ proprietary platform identifies biomarkers that significantly changed pre- and post-consumption of medical cannabis.

  • Samples from neurotypical children are collected and analyzed to determine the biomarkers  baseline for healthy physiological range.

shutterstock_429937732 [Converted]-07.pn

4

shutterstock_429937732 [Converted]-07.pn

5

REPORTS
  • Study participants will receive a report showing their individual changes in biomarkers related to ASD symptoms before and after medical cannabis consumption.

  • We will seek to publish the finding in a scientific peer-reviewed medical journal, across mainstream media and at Cannformatics.com.

web2-01.jpg
Frame 1 (8) (1).png

OUR GOAL

To be a trusted resource for parents and health care professionals by providing data and insights to build an effective cannabis regimen for children with ASD.

OUR ADVISORS
Frame 36 (1).png
STEPHANY COX, PHD

Autism Advisor

Pediatric Neuropsychologist, UCSF

Tamar-Maritz-e1568279697515.jpg
TAMAR MARITZ, MBA

CA Cannabis Market Advisor

VP Business Development, BDS Analytics

wpa4a_logo_transparent_bg.png
Canniatric_Horizontal_colour_RGB_300dpi.
OUR VALUED SPONSORS
BonniGoldstein.png
BONNI GOLDSTEIN, MD

Clinical Advisor

Canna Center LOGO.png